Company intelligence / Profile preview

Matís

Reykjavik, Icelandmatis.is ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Matís conducts advanced R&D projects focused on value creation in the bioeconomy through innovations in food safety, biotechnology, aquaculture genetics, nutrient analysis, microbial ecology of foods/gut health studies. The company collaborates widely with academia and industry across Europe. No clinical trial results as it does not develop pharmaceuticals directly.

Therapeutic areas: OtherInfectious Diseases
Modalities: Biologic (for food/ingredient innovation)Microbial therapy (research on microbiome and microorganisms in food)Enzyme replacement therapy (enzyme activity research for food processing)Small molecule (nutrient analysis and bioactive compounds from natural sources)
Industry: Academic Hospital/University/Research

Partnerships

University of IcelandVarious European universities/institutes via EU-funded consortia

Beyond the preview

Go deeper on Matís.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matís.

Explore the full profile